False information: The European Commission publishes the decision imposing a fine of €7.5 million on a pharmaceutical and chemical company for providing misleading information in the context of the investigation into its acquisition by a competitor (Sigma-Aldrich / Merck)

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. On March 16, 2022, the European Commission made public the decision of May 3, 2021 in which it imposed a fine of EUR 7.5 million on Sigma-Aldrich for providing incorrect or misleading information during the Commission's investigation under the EU Merger Regulation into Merck's acquisition of Sigma-Aldrich. On April 21, 2015, Merck notified the Commission of its proposed acquisition of Sigma-Aldrich. The Commission's investigation identified competition concerns regarding certain laboratory chemicals, namely solvents and inorganic products used in laboratories by companies and research centers. For these products, Merck and Sigma-Aldrich (i) were the two

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

  • L’actu-concurrence (Paris)

Quotation

Alain Ronzano, False information: The European Commission publishes the decision imposing a fine of €7.5 million on a pharmaceutical and chemical company for providing misleading information in the context of the investigation into its acquisition by a competitor (Sigma-Aldrich / Merck), 3 May 2021, Concurrences N° 1-2022, Art. N° 105772, www.concurrences.com

Visites 75

All reviews